{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:21:59Z","timestamp":1789708919591,"version":"4.0.1"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"am","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021976","name":"Medical Technology Enterprise Consortium","doi-asserted-by":"publisher","award":["#W81XWH-15\\u20139-0001"],"award-info":[{"award-number":["#W81XWH-15\\u20139-0001"]}],"id":[{"id":"10.13039\/100021976","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.actbio.2024.10.021","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T20:06:59Z","timestamp":1729109219000},"page":"57-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Regenerative medicine approaches for the treatment of spinal cord injuries: Progress and challenges"],"prefix":"10.1016","volume":"189","author":[{"given":"Patrick C.","family":"Ralph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Woo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jung","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3899-1909","authenticated-orcid":false,"given":"Sang Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0001","first-page":"1","article-title":"Epidemiology of worldwide spinal cord injury: a literature review","volume":"6","author":"Kang","year":"2018","journal-title":"J. Neurorestoratol."},{"issue":"5274","key":"10.1016\/j.actbio.2024.10.021_bib0002","first-page":"510","article-title":"Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function","volume":"273","author":"Cheng","year":"1996","journal-title":"Science (1979)"},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0003","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sc.2014.203","article-title":"Traumatic spinal cord injury in Botswana: characteristics, aetiology and mortality","volume":"53","author":"L\u00f6fvenmark","year":"2015","journal-title":"Spinal Cord."},{"issue":"7","key":"10.1016\/j.actbio.2024.10.021_bib0004","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.brs.0000207258.80129.03","article-title":"Epidemiology of traumatic spinal cord injury in Canada","volume":"31","author":"Pickett","year":"2006","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.actbio.2024.10.021_bib0005","series-title":"Spinal cord injury, Facts and Figures at a Glance","first-page":"1","author":"Center","year":"2020"},{"issue":"22","key":"10.1016\/j.actbio.2024.10.021_bib0006","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.2015.6250","article-title":"Traumatic spinal cord injury in the United States, 1993-2012","volume":"313","author":"Jain","year":"2015","journal-title":"JAMa"},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sc.1995.16","article-title":"A model for estimating spinal cord injury prevalence in the United States","volume":"33","author":"Lasfargues","year":"1995","journal-title":"Spinal Cord."},{"key":"10.1016\/j.actbio.2024.10.021_bib0008","first-page":"309","article-title":"Global prevalence and incidence of traumatic spinal cord injury","volume":"6","author":"Singh","year":"2014","journal-title":"Clin. Epidemiol."},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0009","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41393-020-00533-0","article-title":"A nationwide survey on the incidence and characteristics of traumatic spinal cord injury in Japan in 2018","volume":"59","author":"Miyakoshi","year":"2021","journal-title":"Spinal Cord."},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0010","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/neu.2013.3098","article-title":"The burden of acute traumatic spinal cord injury among adults in the united states: an update","volume":"31","author":"Selvarajah","year":"2014","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.actbio.2024.10.021_bib0011","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2019.01.012","article-title":"Scaffold-facilitated locomotor improvement post complete spinal cord injury: Motor axon regeneration versus endogenous neuronal relay formation","volume":"197","author":"Li","year":"2019","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.actbio.2024.10.021_bib0012","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4103\/1673-5374.274332","article-title":"Multimodal treatment for spinal cord injury: a sword of neuroregeneration upon neuromodulation","volume":"15","author":"Zheng","year":"2020","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3340\/jkns.2019.0146","article-title":"Current status and future strategies to treat spinal cord injury with adult stem cells","volume":"63","author":"Jeong","year":"2020","journal-title":"J. Korean Neurosurg. Soc."},{"key":"10.1016\/j.actbio.2024.10.021_bib0014","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fncel.2019.00248","article-title":"Regeneration of spinal cord connectivity through stem cell transplantation and biomaterial Scaffolds","volume":"13","author":"Katoh","year":"2019","journal-title":"Front. Cell Neurosci."},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/10790268.2017.1329076","article-title":"Assessment and management of acute spinal cord injury: from point of injury to rehabilitation","volume":"40","author":"Hachem","year":"2017","journal-title":"J. Spinal Cord. Med."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/scd.2018.0169","article-title":"Biomaterials and gene manipulation in stem cell-based therapies for spinal cord injury","volume":"28","author":"Wang","year":"2019","journal-title":"Stem Cells Dev."},{"issue":"7806","key":"10.1016\/j.actbio.2024.10.021_bib0017","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41586-020-2200-5","article-title":"Injured adult neurons regress to an embryonic transcriptional growth state","volume":"581","author":"Poplawski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2024.10.021_bib0018","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnagi.2017.00176","article-title":"Targeting microglial activation states as a therapeutic avenue in Parkinson's disease","volume":"9","author":"Subramaniam","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.actbio.2024.10.021_bib0019","article-title":"Mechanism of ferroptosis and its role in spinal cord injury","volume":"13","author":"Li","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.actbio.2024.10.021_bib0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2018.10.023","article-title":"Ferroptosis inhibitor SRS 16-86 attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury","volume":"1706","author":"Zhang","year":"2019","journal-title":"Brain Res."},{"issue":"17","key":"10.1016\/j.actbio.2024.10.021_bib0021","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.3390\/cells11172692","article-title":"Inflammation: a target for treatment in spinal cord injury","volume":"11","author":"Freyermuth-Trujillo","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.actbio.2024.10.021_bib0022","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10571-015-0313-4","article-title":"Inhibition of epidermal growth factor receptor improves myelination and attenuates tissue damage of spinal cord injury","volume":"36","author":"Zhang","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.actbio.2024.10.021_bib0023","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fncel.2018.00368","article-title":"CSF1R inhibition reduces microglia proliferation, promotes tissue preservation and improves motor recovery after spinal cord injury","volume":"12","author":"Gerber","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.actbio.2024.10.021_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.767888","article-title":"Hematogenous macrophages: a new therapeutic target for spinal cord injury","volume":"9","author":"Ding","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.actbio.2024.10.021_bib0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jot.2019.10.006","article-title":"N. International Association of, N. The Chinese Association of, clinical neurorestorative therapeutic guidelines for spinal cord injury (IANR\/CANR version 2019)","volume":"20","author":"Huang","year":"2020","journal-title":"J. Orthop. Translat."},{"key":"10.1016\/j.actbio.2024.10.021_bib0026","article-title":"The role of growth factors in the repair of motor injury","volume":"13","author":"Tan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actbio.2024.10.021_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.792764","article-title":"Reactive astrocytes in central nervous system injury: subgroup and potential therapy","volume":"15","author":"Yu","year":"2021","journal-title":"Front. Cell Neurosci."},{"issue":"632","key":"10.1016\/j.actbio.2024.10.021_bib0028","doi-asserted-by":"crossref","first-page":"eabm4107","DOI":"10.1126\/scitranslmed.abm4107","article-title":"Astrocytic alpha2-Na(+)\/K(+) ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model","volume":"14","author":"Mann","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actbio.2024.10.021_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113032","article-title":"Recent advances in the therapeutic uses of chondroitinase ABC","volume":"321","author":"Muir","year":"2019","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cns.12984","article-title":"Feasible stabilization of chondroitinase abc enables reduced astrogliosis in a chronic model of spinal cord injury","volume":"25","author":"Raspa","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.actbio.2024.10.021_bib0031","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.npep.2017.06.002","article-title":"Combine effect of Chondroitinase ABC and low level laser (660 nm) on spinal cord injury model in adult male rats","volume":"65","author":"Janzadeh","year":"2017","journal-title":"Neuropeptides"},{"issue":"7539","key":"10.1016\/j.actbio.2024.10.021_bib0032","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature13974","article-title":"Modulation of the proteoglycan receptor PTPsigma promotes recovery after spinal cord injury","volume":"518","author":"Lang","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0033","doi-asserted-by":"crossref","first-page":"e11505","DOI":"10.15252\/emmm.201911505","article-title":"Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem","volume":"12","author":"Griffin","year":"2020","journal-title":"EMBo Mol. Med."},{"issue":"7","key":"10.1016\/j.actbio.2024.10.021_bib0034","doi-asserted-by":"crossref","first-page":"914","DOI":"10.5966\/sctm.2015-0381","article-title":"Concise review: bridging the gap: novel neuroregenerative and neuroprotective strategies in spinal cord injury","volume":"5","author":"Ahuja","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0035","first-page":"1","article-title":"Comparison of neuroregeneration in central nervous system and peripheral nervous system","volume":"3","author":"Moattari","year":"2018","journal-title":"Otorhinolaryngol. Neck Surg."},{"key":"10.1016\/j.actbio.2024.10.021_bib0036","first-page":"1","article-title":"The struggle to make CNS axons regenerate: why has it been so difficult?","author":"Fawcett","year":"2019","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0037","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1756-6606-7-22","article-title":"iPS cell technologies: significance and applications to CNS regeneration and disease","volume":"7","author":"Okano","year":"2014","journal-title":"Mol. Brain"},{"issue":"5903","key":"10.1016\/j.actbio.2024.10.021_bib0038","first-page":"963","article-title":"Promoting axon regeneration in the adult CNS by modulation of the PTEN\/mTOR pathway","volume":"322","author":"Park","year":"2008","journal-title":"Science (1979)"},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0039","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.stem.2008.06.011","article-title":"Stem cells for spinal cord repair","volume":"3","author":"Barnab\u00e9-Heider","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"5903","key":"10.1016\/j.actbio.2024.10.021_bib0040","first-page":"967","article-title":"PirB is a functional receptor for myelin inhibitors of axonal regeneration","volume":"322","author":"Atwal","year":"2008","journal-title":"Science (1979)"},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0041","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1083\/jcb.106.4.1281","article-title":"Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading","volume":"106","author":"Caroni","year":"1988","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0042","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0896-6273(88)90212-7","article-title":"Antibody against myelin associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter","volume":"1","author":"Caroni","year":"1988","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0043","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020602","article-title":"Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia","volume":"7","author":"Silver","year":"2015","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0044","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/glia.10315","article-title":"Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration","volume":"46","author":"Sandvig","year":"2004","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.actbio.2024.10.021_bib0045","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001867","article-title":"Guidance molecules in axon regeneration","volume":"2","author":"Giger","year":"2010","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0046","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1038\/s41598-018-37819-6","article-title":"Semaphorin 3A inhibits nerve regeneration during early stage after inferior alveolar nerve transection","volume":"9","author":"Kanemaru","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0047","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1523\/JNEUROSCI.3547-03.2004","article-title":"Reactive astrocytes protect tissue and preserve function after spinal cord injury","volume":"24","author":"Faulkner","year":"2004","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.actbio.2024.10.021_bib0048","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/wound.2019.1046","article-title":"Cell therapeutic strategies for spinal cord injury","volume":"8","author":"Zhou","year":"2019","journal-title":"Adv. Wound Care (New. Rochelle)"},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0049","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12264-013-1359-2","article-title":"Combination treatment with chondroitinase ABC in spinal cord injury\u2014breaking the barrier","volume":"29","author":"Zhao","year":"2013","journal-title":"Neurosci. Bull."},{"issue":"5","key":"10.1016\/j.actbio.2024.10.021_bib0050","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1523\/JNEUROSCI.2661-13.2014","article-title":"Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury","volume":"34","author":"Kanno","year":"2014","journal-title":"J. Neurosci."},{"issue":"7723","key":"10.1016\/j.actbio.2024.10.021_bib0051","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41586-018-0467-6","article-title":"Required growth facilitators propel axon regeneration across complete spinal cord injury","volume":"561","author":"Anderson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2024.10.021_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2019.02.038","article-title":"Stem cell paracrine effect and delivery strategies for spinal cord injury regeneration","author":"Veneruso","year":"2019","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.actbio.2024.10.021_bib0053","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biomaterials.2018.01.015","article-title":"Perineurium-like sheath derived from long-term surviving mesenchymal stem cells confers nerve protection to the injured spinal cord","volume":"160","author":"Ma","year":"2018","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0054","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/1673-5374.244778","article-title":"Mesenchymal stem cells and the neuronal microenvironment in the area of spinal cord injury","volume":"14","author":"Mukhamedshina","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.blre.2005.01.005","article-title":"Therapeutic potential of embryonic stem cells","volume":"19","author":"Lerou","year":"2005","journal-title":"Blood Rev."},{"issue":"5391","key":"10.1016\/j.actbio.2024.10.021_bib0056","first-page":"1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science (1979)"},{"issue":"11","key":"10.1016\/j.actbio.2024.10.021_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007706","article-title":"Roles of ES cell-derived gliogenic neural stem\/progenitor cells in functional recovery after spinal cord injury","volume":"4","author":"Kumagai","year":"2009","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.actbio.2024.10.021_bib0058","doi-asserted-by":"crossref","first-page":"708","DOI":"10.5966\/sctm.2014-0215","article-title":"Allogeneic neural stem\/progenitor cells derived from embryonic stem cells promote functional recovery after transplantation into injured spinal cord of nonhuman primates","volume":"4","author":"Iwai","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0059","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/biores.2019.0046","article-title":"Induced pluripotent stem cells: reprogramming platforms and applications in cell replacement therapy","volume":"9","author":"Al Abbar","year":"2020","journal-title":"Biores. Open Access"},{"issue":"40","key":"10.1016\/j.actbio.2024.10.021_bib0061","doi-asserted-by":"crossref","first-page":"16825","DOI":"10.1073\/pnas.1108077108","article-title":"Grafted human-induced pluripotent stem-cell\u2013derived neurospheres promote motor functional recovery after spinal cord injury in mice","volume":"108","author":"Nori","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.actbio.2024.10.021_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052787","article-title":"Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity","volume":"7","author":"Kobayashi","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0063","first-page":"65","article-title":"Cell transplantation in spinal cord injury","volume":"8","author":"Soo Lee","year":"2018","journal-title":"J. Adv. Spine Surg."},{"issue":"7","key":"10.1016\/j.actbio.2024.10.021_bib0064","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrneurol.2010.73","article-title":"Stem cell therapies for spinal cord injury","volume":"6","author":"Sahni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.actbio.2024.10.021_bib0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.expneurol.2013.12.022","article-title":"Neuroprotective effects of human spinal cord-derived neural precursor cells after transplantation to the injured spinal cord","volume":"253","author":"Emg\u00e5rd","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.actbio.2024.10.021_bib0066","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1227\/01.neu.0000489741.54469.a1","article-title":"172; A Phase I, open-label, single-site, safety study of human spinal cord-derived neural stem cell transplantation for the treatment of chronic spinal cord injury","volume":"63","author":"Curtis","year":"2016","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0067","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/cts.12394","article-title":"Human embryonic stem cell therapy in chronic spinal cord injury: a retrospective study","volume":"9","author":"Shroff","year":"2016","journal-title":"Clin. Transl. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0068","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4252\/wjsc.v6.i2.120","article-title":"Mesenchymal stem cells in the treatment of spinal cord injuries: a review","volume":"6","author":"Dasari","year":"2014","journal-title":"World J. Stem Cells"},{"issue":"8","key":"10.1016\/j.actbio.2024.10.021_bib0069","first-page":"1017","article-title":"Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials","volume":"91","author":"Lu","year":"2006","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0070","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.molmed.2017.07.005","article-title":"Current options for cell therapy in spinal cord injury","volume":"23","author":"Vismara","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.actbio.2024.10.021_bib0071","series-title":"Advances in Multiple Sclerosis and Experimental Demyelinating Diseases","first-page":"193","article-title":"Remyelination in experimental models of toxin-induced demyelination","author":"Blakemore","year":"2008"},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0072","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0896-6273(94)90208-9","article-title":"Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment","volume":"12","author":"Gillespie","year":"1994","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0073","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/glia.20992","article-title":"Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury","volume":"58","author":"Park","year":"2010","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.actbio.2024.10.021_bib0074","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/neu.2008.0809","article-title":"Suspension matrices for improved Schwann-cell survival after implantation into the injured rat spinal cord","volume":"27","author":"Patel","year":"2010","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cne.903120311","article-title":"PNS-CNS transitional zone of the first cranial nerve","volume":"312","author":"Doucette","year":"1991","journal-title":"J. Comp. Neurol."},{"issue":"46","key":"10.1016\/j.actbio.2024.10.021_bib0076","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1523\/JNEUROSCI.3632-05.2005","article-title":"Lamina propria and olfactory bulb ensheathing cells exhibit differential integration and migration and promote differential axon sprouting in the lesioned spinal cord","volume":"25","author":"Richter","year":"2005","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0077","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1172\/JCI42957","article-title":"Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury","volume":"120","author":"Abematsu","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.actbio.2024.10.021_bib0078","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1089\/ten.tea.2008.0364","article-title":"Neural stem cell\u2013and schwann cell\u2013loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord","volume":"15","author":"Olson","year":"2009","journal-title":"Tissue Eng. Part A"},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0079","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/npp.2013.237","article-title":"Regenerative therapies for central nervous system diseases: a biomaterials approach","volume":"39","author":"Tam","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.actbio.2024.10.021_bib0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biomaterials.2015.01.078","article-title":"On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology","volume":"52","author":"Shao","year":"2015","journal-title":"Biomaterials"},{"issue":"34","key":"10.1016\/j.actbio.2024.10.021_bib0081","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1002\/adma.201502767","article-title":"Hybrid crosslinked methylcellulose hydrogel: a predictable and tunable platform for local drug delivery","volume":"27","author":"Pakulska","year":"2015","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.2009.0948","article-title":"Biomaterial design strategies for the treatment of spinal cord injuries","volume":"27","author":"Straley","year":"2010","journal-title":"J. Neurotrauma"},{"issue":"8","key":"10.1016\/j.actbio.2024.10.021_bib0083","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4103\/1673-5374.253512","article-title":"Role and prospects of regenerative biomaterials in the repair of spinal cord injury","volume":"14","author":"Liu","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107517","article-title":"The effects of controlled release of neurotrophin-3 from PCLA scaffolds on the survival and neuronal differentiation of transplanted neural stem cells in a rat spinal cord injury model","volume":"9","author":"Tang","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1098\/rsfs.2012.0016","article-title":"Hyaluronic acid-based scaffold for central neural tissue engineering","volume":"2","author":"Wang","year":"2012","journal-title":"Interface Focus."},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0086","article-title":"Neural precursor cells generated from Induced pluripotent stem cells with gelatin sponge-electrospun PLGA\/PEG nanofibers for spinal cord injury repair","volume":"9","author":"Pang","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0087","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/brb3.145","article-title":"Enhanced peripheral nerve regeneration by the combination of a polycaprolactone tubular prosthesis and a scaffold of collagen with supramolecular organization","volume":"3","author":"Maturana","year":"2013","journal-title":"Brain Behav."},{"key":"10.1016\/j.actbio.2024.10.021_bib0088","doi-asserted-by":"crossref","DOI":"10.1080\/14712598.2020.1770725","article-title":"Regenerative medicine for spinal cord injury: focus on stem cells and biomaterials","author":"Papa","year":"2020","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.actbio.2024.10.021_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122002","article-title":"Microenvironmental modulation in tandem with human stem cell transplantation enhances functional recovery after chronic complete spinal cord injury","volume":"295","author":"Hashimoto","year":"2023","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.actbio.2024.10.021_bib0090","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jbm.a.36011","article-title":"Collagen\/heparin sulfate scaffolds fabricated by a 3D bioprinter improved mechanical properties and neurological function after spinal cord injury in rats","volume":"105","author":"Chen","year":"2017","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.actbio.2024.10.021_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120771","article-title":"3D bioprinted neural tissue constructs for spinal cord injury repair","volume":"272","author":"Liu","year":"2021","journal-title":"Biomaterials"},{"issue":"39","key":"10.1016\/j.actbio.2024.10.021_bib0092","article-title":"3D printed stem-cell derived neural progenitors generate spinal cord scaffolds","volume":"28","author":"Joung","year":"2018","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0093","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41591-018-0296-z","article-title":"Biomimetic 3D-printed scaffolds for spinal cord injury repair","volume":"25","author":"Koffler","year":"2019","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.actbio.2024.10.021_bib0094","doi-asserted-by":"crossref","first-page":"e12137","DOI":"10.1002\/jev2.12137","article-title":"Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-beta upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury","volume":"10","author":"Nakazaki","year":"2021","journal-title":"J. ExtraCell Vesicles"},{"key":"10.1016\/j.actbio.2024.10.021_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105339","article-title":"Exosomes derived from NGF-overexpressing bone marrow mesenchymal stem cell sheet promote spinal cord injury repair in a mouse model","volume":"157","author":"Li","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.actbio.2024.10.021_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135399","article-title":"Exosomes derived from human placenta-derived mesenchymal stem cells improve neurologic function by promoting angiogenesis after spinal cord injury","volume":"739","author":"Zhang","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"13","key":"10.1016\/j.actbio.2024.10.021_bib0097","doi-asserted-by":"crossref","first-page":"16355","DOI":"10.1021\/acsami.2c19607","article-title":"Bioactive spinal cord scaffold releasing neurotrophic exosomes to promote in situ centralis neuroplasticity","volume":"15","author":"Mi","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"13","key":"10.1016\/j.actbio.2024.10.021_bib0098","article-title":"Exosomes-loaded electroconductive hydrogel synergistically promotes tissue repair after spinal cord injury via immunoregulation and enhancement of myelinated axon growth","volume":"9","author":"Fan","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0099","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s13287-021-02401-x","article-title":"SiRNA in MSC-derived exosomes silences CTGF gene for locomotor recovery in spinal cord injury rats","volume":"12","author":"Huang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0100","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1021\/acs.nanolett.0c00929","article-title":"Transplantation of human mesenchymal stem-cell-derived exosomes immobilized in an adhesive hydrogel for effective treatment of spinal cord injury","volume":"20","author":"Li","year":"2020","journal-title":"Nano Lett."},{"issue":"18","key":"10.1016\/j.actbio.2024.10.021_bib0101","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2217\/nnm-2021-0025","article-title":"Bone mesenchymal stem cell-derived exosome-loaded injectable hydrogel for minimally invasive treatment of spinal cord injury","volume":"16","author":"Cheng","year":"2021","journal-title":"Nanomedicine (Lond)"},{"issue":"7","key":"10.1016\/j.actbio.2024.10.021_bib0102","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1039\/D1BM01722E","article-title":"Hypoxia-stimulated mesenchymal stem cell-derived exosomes loaded by adhesive hydrogel for effective angiogenic treatment of spinal cord injury","volume":"10","author":"Mu","year":"2022","journal-title":"Biomater. Sci."},{"issue":"15","key":"10.1016\/j.actbio.2024.10.021_bib0103","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1021\/acs.nanolett.2c02259","article-title":"Three-dimensional-cultured MSC-derived exosome-hydrogel hybrid microneedle array patch for spinal cord repair","volume":"22","author":"Han","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2024.10.021_bib0104","doi-asserted-by":"crossref","first-page":"43559","DOI":"10.1038\/srep43559","article-title":"Transplantation of hUC-MSCs seeded collagen scaffolds reduces scar formation and promotes functional recovery in canines with chronic spinal cord injury","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"9-10","key":"10.1016\/j.actbio.2024.10.021_bib0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/ten.tea.2016.0378","article-title":"Hierarchically ordered porous and high-volume polycaprolactone microchannel scaffolds enhanced axon growth in transected spinal cords","volume":"23","author":"Shahriari","year":"2017","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.actbio.2024.10.021_bib0106","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.actbio.2017.07.024","article-title":"Regulated viral BDNF delivery in combination with Schwann cells promotes axonal regeneration through capillary alginate hydrogels after spinal cord injury","volume":"60","author":"Liu","year":"2017","journal-title":"Acta Biomater."},{"issue":"17","key":"10.1016\/j.actbio.2024.10.021_bib0107","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1111\/febs.14603","article-title":"Impaired neural stem cell expansion and hypersensitivity to epileptic seizures in mice lacking the EGFR in the brain","volume":"285","author":"Robson","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.actbio.2024.10.021_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112233","article-title":"The combination of nanoscaffolds and stem cell transplantation: Paving a promising road for spinal cord injury regeneration","volume":"143","author":"Chen","year":"2021","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.actbio.2024.10.021_bib0109","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biomaterials.2015.10.024","article-title":"A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury","volume":"75","author":"Caron","year":"2016","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4184\/asj.2016.10.4.611","article-title":"Transplantation of neural stem cells cultured in alginate scaffold for spinal cord injury in rats","volume":"10","author":"Hosseini","year":"2016","journal-title":"Asian Spine J."},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0111","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3346\/jkms.2016.31.9.1373","article-title":"Transplantation of mesenchymal stem cells for acute spinal cord injury in rats: comparative study between intralesional injection and scaffold based transplantation","volume":"31","author":"Kim","year":"2016","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0112","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00441-016-2402-1","article-title":"Chitosan scaffolds induce human dental pulp stem cells to neural differentiation: potential roles for spinal cord injury therapy","volume":"366","author":"Zhang","year":"2016","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0113","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ab785f","article-title":"A chitosan-based thermosensitive scaffold loaded with bone marrow-derived mesenchymal stem cells promotes motor function recovery in spinal cord injured mice","volume":"15","author":"Zhang","year":"2020","journal-title":"Biomed. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0114","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11427-016-9002-6","article-title":"Human placenta-derived mesenchymal stem cells loaded on linear ordered collagen scaffold improves functional recovery after completely transected spinal cord injury in canine","volume":"61","author":"Han","year":"2018","journal-title":"Sci. China Life Sci."},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0115","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201601279","article-title":"A dual functional scaffold tethered with EGFR antibody promotes neural stem cell retention and neuronal differentiation for spinal cord injury repair","volume":"6","author":"Xu","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2024.10.021_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119941","article-title":"A functional scaffold to promote the migration and neuronal differentiation of neural stem\/progenitor cells for spinal cord injury repair","volume":"243","author":"Liu","year":"2020","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.actbio.2024.10.021_bib0117","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4103\/1673-5374.268974","article-title":"Three-dimensional bioprinting collagen\/silk fibroin scaffold combined with neural stem cells promotes nerve regeneration after spinal cord injury","volume":"15","author":"Jiang","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.actbio.2024.10.021_bib0118","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ijbiomac.2020.01.219","article-title":"Human embryonic stem cell-derived neural stem cells encapsulated in hyaluronic acid promotes regeneration in a contusion spinal cord injured rat","volume":"148","author":"Zarei-Kheirabadi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0119","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acsami.6b12829","article-title":"Peptide-tethered hydrogel scaffold promotes recovery from spinal cord transection via synergism with mesenchymal stem cells","volume":"9","author":"Li","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0120","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1039\/C9BM01530B","article-title":"Implantation of a functional TEMPO-hydrogel induces recovery from rat spinal cord transection through promoting nerve regeneration and protecting bladder tissue","volume":"8","author":"Zhang","year":"2020","journal-title":"Biomater. Sci."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0121","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/jbm.a.36311","article-title":"Injectable hydroxyphenyl derivative of hyaluronic acid hydrogel modified with RGD as scaffold for spinal cord injury repair","volume":"106","author":"Zaviskova","year":"2018","journal-title":"J. Biomed. Mater. Res. Part A"},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0122","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1038\/s41598-020-59148-3","article-title":"The effect of Matrigel as scaffold material for neural stem cell transplantation for treating spinal cord injury","volume":"10","author":"Wang","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0123","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s12276-018-0054-9","article-title":"Brain and spinal cord injury repair by implantation of human neural progenitor cells seeded onto polymer scaffolds","volume":"50","author":"Shin","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.actbio.2024.10.021_bib0124","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120062","article-title":"Rapid prototyping fabrication of soft and oriented polyester scaffolds for axonal guidance","volume":"251","author":"Kaplan","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2024.10.021_bib0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41393-020-0455-1","article-title":"A scoping review of trials for cell-based therapies in human spinal cord injury","author":"Willison","year":"2020","journal-title":"Spinal Cord."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0126","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3171\/2014.5.SPINE13992","article-title":"Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: case report","volume":"21","author":"Dlouhy","year":"2014","journal-title":"J. Neurosurg. Spine"},{"issue":"27","key":"10.1016\/j.actbio.2024.10.021_bib0127","doi-asserted-by":"crossref","first-page":"E761","DOI":"10.1503\/cmaj.181696","article-title":"Intramedullary cervical spinal mass after stem cell transplantation using an olfactory mucosal cell autograft","volume":"191","author":"Woodworth","year":"2019","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0128","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/0963689718766279","article-title":"Significant improvement of acute complete spinal cord injury patients diagnosed by a combined criteria implanted with neuroregen scaffolds and mesenchymal stem cells","volume":"27","author":"Xiao","year":"2018","journal-title":"Cell TransPlant"},{"issue":"5","key":"10.1016\/j.actbio.2024.10.021_bib0129","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3727\/096368917X695038","article-title":"Clinical study of NeuroRegen scaffold combined with human mesenchymal stem cells for the repair of chronic complete spinal cord injury","volume":"26","author":"Zhao","year":"2017","journal-title":"Cell TransPlant"},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0130","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.1227\/NEU.0000000000001283","article-title":"First human implantation of a bioresorbable polymer scaffold for acute traumatic spinal cord injury: a clinical pilot study for safety and feasibility","volume":"79","author":"Theodore","year":"2016","journal-title":"Neurosurgery"},{"issue":"11","key":"10.1016\/j.actbio.2024.10.021_bib0131","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3727\/096368916X691411","article-title":"Phase I-II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury","volume":"25","author":"Zhu","year":"2016","journal-title":"Cell TransPlant"},{"issue":"8","key":"10.1016\/j.actbio.2024.10.021_bib0132","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1634\/stemcells.2006-0807","article-title":"Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I\/II clinical trial","volume":"25","author":"Yoon","year":"2007","journal-title":"Stem Cells (1981)"},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0133","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.sc.3102008","article-title":"Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures","volume":"45","author":"Steeves","year":"2007","journal-title":"Spinal Cord."},{"issue":"5","key":"10.1016\/j.actbio.2024.10.021_bib0134","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s11999-016-5133-4","article-title":"Classifications in brief: American spinal injury association (ASIA) impairment scale","volume":"475","author":"Roberts","year":"2017","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0135","first-page":"127","article-title":"Administration of cultured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: a pilot study","volume":"30","author":"Saito","year":"2012","journal-title":"Restor. Neurol. Neurosci."},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0136","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jcyt.2018.03.032","article-title":"Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: safety and efficacy of the 100\/3 guideline","volume":"20","author":"Vaquero","year":"2018","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0137","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1179\/2045772315Y.0000000048","article-title":"Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: a human trial","volume":"39","author":"Hur","year":"2016","journal-title":"J. Spinal Cord. Med."},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0138","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3727\/096368913X664540","article-title":"Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients","volume":"23","author":"El-Kheir","year":"2014","journal-title":"Cell TransPlant"},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0139","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1227\/NEU.0000000000001056","article-title":"A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury","volume":"78","author":"Oh","year":"2016","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jcyt.2016.12.002","article-title":"Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury","volume":"19","author":"Vaquero","year":"2017","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0141","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3727\/096368912X663532","article-title":"Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury","volume":"22","author":"Tabakow","year":"2013","journal-title":"Cell TransPlant"},{"issue":"10","key":"10.1016\/j.actbio.2024.10.021_bib0142","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jcyt.2017.06.006","article-title":"Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study","volume":"19","author":"Larocca","year":"2017","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0143","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/scrt516","article-title":"Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury","volume":"5","author":"Mendon\u00e7a","year":"2014","journal-title":"Stem Cell Res. Ther."},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0144","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.stem.2018.05.014","article-title":"A first-in-human, phase I study of neural stem cell transplantation for chronic spinal cord injury","volume":"22","author":"Curtis","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"21","key":"10.1016\/j.actbio.2024.10.021_bib0145","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1089\/neu.2016.4895","article-title":"Safety of autologous human schwann cell transplantation in subacute thoracic spinal cord injury","volume":"34","author":"Anderson","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"9","key":"10.1016\/j.actbio.2024.10.021_bib0146","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4103\/1673-5374.276340","article-title":"Collagen scaffold combined with human umbilical cord-mesenchymal stem cells transplantation for acute complete spinal cord injury","volume":"15","author":"Deng","year":"2020","journal-title":"Neural Regen. Res."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0147","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jcyt.2016.01.004","article-title":"Autologous mesenchymal stromal cell transplantation for spinal cord injury: a phase I pilot study","volume":"18","author":"Satti","year":"2016","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0148","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sc.2015.142","article-title":"Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome","volume":"54","author":"Oraee-Yazdani","year":"2016","journal-title":"Spinal Cord."},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0149","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5966\/sctm.2013-0141","article-title":"Preliminary study of autologous bone marrow nucleated cells transplantation in children with spinal cord injury","volume":"3","author":"Jarocha","year":"2014","journal-title":"Stem Cells Transl. Med."},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2176\/nmc.oa.2015-0320","article-title":"A pilot clinical study of olfactory mucosa autograft for chronic complete spinal cord injury","volume":"56","author":"Iwatsuki","year":"2016","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0151","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1545968309347685","article-title":"Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury","volume":"24","author":"Lima","year":"2010","journal-title":"Neurorehabil. Neural Repair."},{"issue":"1_suppl","key":"10.1016\/j.actbio.2024.10.021_bib0152","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3727\/096368914X684899","article-title":"Transplantation of purified autologous leukapheresis-derived CD34+ and CD133+ stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy","volume":"23","author":"Al-Zoubi","year":"2014","journal-title":"Cell TransPlant"},{"key":"10.1016\/j.actbio.2024.10.021_bib0153","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/630932","article-title":"Clinical trial of human fetal brain-derived neural stem\/progenitor cell transplantation in patients with traumatic cervical spinal cord injury","volume":"2015","author":"Shin","year":"2015","journal-title":"Neural Plast."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0154","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sc.2015.134","article-title":"Autologous bone marrow cell transplantation in acute spinal cord injury\u2013an Indian pilot study","volume":"54","author":"Chhabra","year":"2016","journal-title":"Spinal Cord."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0155","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/02688697.2010.550658","article-title":"Autologous mesenchymal stem cells in chronic spinal cord injury","volume":"25","author":"Bhanot","year":"2011","journal-title":"Br. J. Neurosurg."},{"issue":"8","key":"10.1016\/j.actbio.2024.10.021_bib0156","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jcyt.2016.05.003","article-title":"An approach to personalized cell therapy in chronic complete paraplegia: the Puerta de Hierro phase I\/II clinical trial","volume":"18","author":"Vaquero","year":"2016","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.actbio.2024.10.021_bib0157","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcyt.2018.04.006","article-title":"Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyelia","volume":"20","author":"Vaquero","year":"2018","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0158","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/neuros\/nyx250","article-title":"Emerging safety of intramedullary transplantation of human neural stem cells in chronic cervical and thoracic spinal cord injury","volume":"82","author":"Levi","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.actbio.2024.10.021_bib0159","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12967-014-0253-7","article-title":"Clinical observation of umbilical cord mesenchymal stem cell transplantation in treatment for sequelae of thoracolumbar spinal cord injury","volume":"12","author":"Cheng","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.actbio.2024.10.021_bib0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2013.08.016","article-title":"Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury","volume":"1533","author":"Dai","year":"2013","journal-title":"Brain Res."},{"issue":"3-4","key":"10.1016\/j.actbio.2024.10.021_bib0161","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/neu.2020.7590","article-title":"Phase 1 safety trial of autologous human schwann cell transplantation in chronic spinal cord injury","volume":"39","author":"Gant","year":"2022","journal-title":"J. Neurotrauma"},{"issue":"8","key":"10.1016\/j.actbio.2024.10.021_bib0162","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jcyt.2024.03.480","article-title":"Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I\/II study","volume":"26","author":"Awidi","year":"2024","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0163","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41467-024-48979-7","article-title":"Author correction: intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial","volume":"15","author":"Bydon","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0164","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/brain\/awr339","article-title":"Transplanted neural stem\/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord","volume":"135","author":"Cusimano","year":"2012","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1545968306286976","article-title":"Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord","volume":"20","author":"Himes","year":"2006","journal-title":"Neurorehabil. Neural Repair."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0166","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1073\/pnas.042678299","article-title":"Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery","volume":"99","author":"Hofstetter","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.actbio.2024.10.021_bib0167","doi-asserted-by":"crossref","first-page":"567","DOI":"10.21037\/jss.2017.10.06","article-title":"Does timing of transplantation of neural stem cells following spinal cord injury affect outcomes in an animal model?","volume":"3","author":"Cheng","year":"2017","journal-title":"J. Spine Surg."},{"issue":"1","key":"10.1016\/j.actbio.2024.10.021_bib0168","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-6-3","article-title":"Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury","volume":"6","author":"Nishimura","year":"2013","journal-title":"Mol. Brain"},{"issue":"13","key":"10.1016\/j.actbio.2024.10.021_bib0169","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1523\/JNEUROSCI.4184-05.2006","article-title":"Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury","volume":"26","author":"Karimi-Abdolrezaee","year":"2006","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.actbio.2024.10.021_bib0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1359-6446(02)02255-9","article-title":"Hydrogels: from controlled release to pH-responsive drug delivery","volume":"7","author":"Gupta","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.actbio.2024.10.021_bib0171","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122400","article-title":"Custom-engineered hydrogels for delivery of human iPSC-derived neurons into the injured cervical spinal cord","volume":"305","author":"Doulames","year":"2024","journal-title":"Biomaterials"},{"issue":"26","key":"10.1016\/j.actbio.2024.10.021_bib0172","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300951","article-title":"An in vitro and ex vivo analysis of the potential of GelMA hydrogels as a therapeutic platform for preclinical spinal cord injury","volume":"12","author":"Walsh","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.actbio.2024.10.021_bib0173","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bit.26074","article-title":"Stem cells for spinal cord injury: strategies to inform differentiation and transplantation","volume":"114","author":"Iyer","year":"2017","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.actbio.2024.10.021_bib0174","article-title":"3D gelatin microsphere scaffolds promote functional recovery after spinal cord hemisection in rats","volume":"10","author":"Ke","year":"2023","journal-title":"Adv. Sci. (Weinh)"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124006135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124006135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:35:39Z","timestamp":1762382139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706124006135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":174,"alternative-id":["S1742706124006135"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2024.10.021","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regenerative medicine approaches for the treatment of spinal cord injuries: Progress and challenges","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2024.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acta Materialia Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}